BIOMAT Database Logo BIOMAT Database Logo

Newly synthesized methionine aminopeptidase 2 inhibitor hinders tumor growth. 2023

Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
Institute for Drug Research, School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, 91120, Jerusalem, Israel.

Methionine aminopeptidase 2 (MetAp2) inhibition has been recognized as a promising approach for suppressing angiogenesis and cancer progression. Small molecule fumagillol derivatives with adamantane side groups were synthesized and evaluated for MetAp2 inhibition activity, and a lead molecule with superior abilities to inhibit the enzymatic activity of MetAp2 was identified. The compound, referred to as AD-3281, effectively suppressed proliferation of cancer and endothelial cells and impaired tube formation of endothelial cells in vitro. When administered systemically, AD-3281 was well tolerated and led to a significant suppression of human melanoma and mammary tumor xenografts grown in mice. The activity in vivo was associated with reduced angiogenesis and tumor proliferation as detected histologically. In order to develop a formulation that can solubilize AD-3281 with a minimal content of organic solvents, biodegradable nanoparticles comprised of poly-lactic-co-glycolic acid (PLGA) were fabricated and characterized. Compared with the free compound, AD-3281-loaded nanoparticles showed an advantageous cellular availability and uptake, leading to higher activity in cells and better transport in three-dimensional (3D) cultures. Taken together, we introduce a novel MetAp2 inhibitor with high anti-cancer activity and a stable nano-formulation with a high potential for future clinical translation.

UI MeSH Term Description Entries
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000626 Aminopeptidases A subclass of EXOPEPTIDASES that act on the free N terminus end of a polypeptide liberating a single amino acid residue. EC 3.4.11. Aminopeptidase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.
November 2003, Cancer research,
Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models.
February 2024, Molecular cancer therapeutics,
Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
July 2003, Journal of medicinal chemistry,
Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
5-demethylovalicin, as a methionine aminopeptidase-2 inhibitor produced by Chrysosporium.
January 2002, Bioorganic & medicinal chemistry,
Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
Microsporidian methionine aminopeptidase type 2.
January 2001, The Journal of eukaryotic microbiology,
Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
Methionine aminopeptidase 2 and cancer.
April 2006, Biochimica et biophysica acta,
Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
Immunomodulatory activity of a methionine aminopeptidase-2 inhibitor on B cell differentiation.
March 2009, Clinical and experimental immunology,
Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
Methionine aminopeptidase 2 expression in microsporidia.
January 2003, The Journal of eukaryotic microbiology,
Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interaction.
January 2015, Molecular therapy. Methods & clinical development,
Rawnaq Esa, and Eliana Steinberg, and Arie Dagan, and Zhanna Yekhtin, and Katerina Tischenko, and Ofra Benny
NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells.
August 2009, Molecular cancer,
Copied contents to your clipboard!